Down’s syndrome Mrs Bincy Varghese Associate Professor Nursing
introduction Down syndrome, also known as T risomy 21 is the most common autosomal chromosome aberration occurring in approximately 1:700 live births. The risk of a T risomy 21 pregnancy rises with increasing maternal age. Clinically T risomy 21 manifests as a syndrome involving a characteristic appearance, organ malformations and mental disability . Down syndrome is by far the most common and best known chromosomal disorder in humans and the most common cause of Intellectual Disability. It is primarily caused by trisomy of chromosome 21. However not all defects occur in each patient; there is a wide range of phenotypic variation.
epidemiology Most common autosomal chromosome aberration (1:700 live births). The risk of a Down syndrome pregnancy rises with maternal age Maternal Age Incidence 20 1:1500 30 1:900 40 1:100 45 1:30 50 1:6
etiology Non-disjunction occurs in approx. 70% of cases in meiosis In about 95% of cases, there is an extra whole chromosome 21 (trisomy 21), which is typically maternally derived. Translocation occurs when genetic material from chromosome 21 becomes attached to another chromosome resulting in 46 chromosomes with 1 chromosome having extra material from chromosome 21 attached.
Clinical features Facial and cranial features (Craniofacial Dysmorphia) Eyes Upward slanting of the eyelids, E picanthal folds , Hypertelorism Brushfield spots Refractive errors (e.g., S hort-sightedness , A stigmatism , S trabismus ) Cataracts (congenital, infantile, or juvenile)
Mouth Small oral cavity, large tongue High arched palate Abnormal teeth Further features Brachycephaly Hypoplastic nasal bones, broad and flat nasal bridge Ear anomalies (small, round low-set ears)
Extremities, soft tissue and skeletal features Single transverse palmar crease Sandal gap Clinodactyly B rachydactyly Soft tissue: ↑ increased risk of umbilical and inguinal hernias ; marked hyperextension of joints may occur Atlantoaxial instability : L oss of ligamentous stability between the atlas (C1) and axis (C2) which can result in compression of the spinal cord
Organ malformations and associated conditions Heart A trioventricular Septal Defect V entricular Septal Defect T etralogy Of Fallot Gastrointestinal tract D uodenal atresia I mperforate Anus E nlargement of the colon R ectal prolapse Hirschsprung disease
Urogenital system H ypogonadism C ryptorchidism D ecreased fertility in men Further features H ypothyroidism C eliac D isease S leep A pnea H earing l oss due to recurrent O titis M edia
↑ risk of L eukemia ↑ risk of early onset of Alzheimer disease ↑ risk of developing E pileps y Height and development Motor skills Delayed motor development Muscle hypotonia Height : R educed growth with shortening of long bones
Obesity : P revalence approx. 50% higher than in general population Intelligence Varying levels of intellectual disability (average IQ: 50) Apparent within first 12 months: D evelopmental milestones (e.g., sitting, walking, talking) achieved at approx. twice the age of healthy children
SIMIAN CREASE
FLAT NASAL BRIDGE
microcephaly
SANDAL GAP
clinodactyly
Diagnostic evaluation Prenatal screening Counselling precedes screening procedures; provide information that screening is voluntary; explain options of terminating the pregnancy if T risomy 21 is diagnosed. Screening procedures First Trimester Combined Test (11–13 weeks) Ultrasound Nuchal Translucency Measurement (thickened nuchal fold), Absent or hypoplastic nasal bone , Shortened middle phalanges of the fifth digits with clinodactyly, Shortened long bones Maternal serum: ↓ ( PAPP-A ); ↑ β- hCG
Second Trimester Quadruple T est (15–18 weeks) Screens for T risomy 1 8 and 21 . ( Trisomy 21: ↓ Free Estriol , ↓ Alpha-Fetoprotein ( AFP ), ↑ I nhibin A and ↑ human chorionic gonadotropin ( β- hCG ) Cell-free fetal DNA ( cfDNA ) Diagnostic F etal K aryotyping : T est used to identify and evaluate the size, shape, and number of chromosomes in a sample of cells. Amniocentesis CVS (Chorionic Villi Sampling)
Postnatal Diagnostics Screening for associated conditions. Treatment Symptomatic Management of the associated conditions Educational awareness, Social support Prognosis Average life expectancy approx. 50 years Mortality mostly due to organ malformation and immunodeficiency.